This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1P Anand , SG Thomas , AB Kunnumakkara , (2008) Biological activities of curcumin and its analogues (congeners) made by man and mother nature. Biochem Pharmacol 76, 1590–1611.
2SK Sandur , MK Pandey , B Sung , (2007) Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and tumerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28, 1765–1773.
3CD Lao , MTt Ruffin , D Normolle , (2006) Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10.
5P Anand , AB Kunnumakkara , RA Newman , (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4, 807–818.
6RA Sharma , WP Steward & AJ Gescher (2007) Pharmacokinetics and pharmacodynamics of curcumin. Adv Exp Med Biol 595, 453–470.
7E Pfeiffer , SI Hoehle , SG Walch , (2007) Curcuminoids form reactive glucuronides in vitro. J Agric Food Chem 55, 538–544.
8SK Vareed , M Kakarala , MT Ruffin , (2008) Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers 17, 1411–1417.
9BB Aggarwal & KB Harikumar (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 41, 40–59.
10M-H Pan , S-Y Lin-Shiau & J-K Lin (2000) Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IκB kinase and NF-κB activation in macrophages. Biochem Pharmacol 60, 1665–1676.
11T Osawa , Y Sugiyama , M Inayoshi , (1995) Antioxidative activity of tetrahydrocurcuminoids. Biosci Biotechnol Biochem 59, 1609–1612.
12M Naito , X Wu , H Nomura , (2002) The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits. J Atheroscler Thromb 9, 243–250.
14RA Sharma , SA Euden , SL Platton , (2004) Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847–6854.
16HP Ammon & MA Wahl (1991) Pharmacology of Curcuma longa. Planta Med 57, 1–7.
17AS Strimpakos & RA Sharma (2008) Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10, 511–545.
18BT Kurien , A Singh , H Matsumoto , (2007) Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev Technol 5, 567–576.
21SK Sandur , H Ichikawa , MK Pandey , (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med 43, 568–580.
22N Chainani-Wu (2003) Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). J Altern Complement Med 9, 161–168.
23S Singh & BB Aggarwal (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24995–25000.
25S Shishodia , HM Amin , R Lai , (2005) Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70, 700–713.
26BB Aggarwal , G Sethi , KS Ahn , (2006) Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci 1091, 151–169.
27AC Bharti , N Donato & BB Aggarwal (2003) Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863–3871.
28GG Mackenzie , N Queisser , ML Wolfson , (2008) Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. Int J Cancer 123, 56–65.
29SS Han , ST Chung , DA Robertson , (1999) Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93, 152–161.
30Y Fujio , K Kunisada , H Hirota , (1997) Signals through gp130 upregulate bcl-x gene expression via STAT1-binding cis-element in cardiac myocytes. J Clin Invest 99, 2898–2905.
31D Sinibaldi , W Wharton , J Turkson , (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19, 5419–5427.
32P Sarraf , E Mueller , WM Smith , (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 3, 799–804.
33YK Nakamura & ST Omaye (2009) Conjugated linoleic acid isomers' roles in the regulation of PPAR-gamma and NF-kappaB DNA binding and subsequent expression of antioxidant enzymes in human umbilical vein endothelial cells. Nutrition 25, 800–811.
34F Ondrey (2009) Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 15, 2–8.
37R Wetzker & FD Bohmer (2003) Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4, 651–657.
38DG Binion , MF Otterson & P Rafiee (2008) Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition. Gut 57, 1509–1517.
39YR Chen & TH Tan (1998) Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173–178.
40GP Collett & FC Campbell (2004) Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25, 2183–2189.
41M Hu , Q Du , I Vancurova , (2005) Proapoptotic effect of curcumin on human neutrophils: activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 33, 2571–2578.
42PJ Moos , K Edes , JE Mullally , (2004) Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25, 1611–1617.
43P Tsvetkov , G Asher , V Reiss , (2005) Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A 102, 5535–5540.
44T Choudhuri , S Pal , T Das , (2005) Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280, 20059–20068.
45G Song , YB Mao , QF Cai , (2005) Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38, 1791–1798.
46B Fisher , JP Costantino , DL Wickerham , (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90, 1371–1388.
50JS Shim , JH Kim , HY Cho , (2003) Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol 10, 695–704.
53AN Cohen , MS Veena , ES Srivatsan , (2009) Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. Arch Otolaryngol Head Neck Surg 135, 190–197.
55MJ Thun , MM Namboodiri & CW Heath Jr (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325, 1593–1596.
56SM Plummer , KA Holloway , MM Manson , (1999) Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013–6020.
57SL Pender & TT MacDonald (2004) Matrix metalloproteinases and the gut – new roles for old enzymes. Curr Opin Pharmacol 4, 546–550.
58P Vihinen , R Ala-aho & VM Kahari (2005) Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 5, 203–220.
59S Yodkeeree , S Garbisa & P Limtrakul (2008) Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol Sin 29, 853–860.
60K Saja , MS Babu , D Karunagaran , (2007) Anti-inflammatory effect of curcumin involves downregulation of MMP-9 in blood mononuclear cells. Int Immunopharmacol 7, 1659–1667.
61RM Claramunt , L Bouissane , MP Cabildo , (2009) Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases. Bioorg Med Chem 17, 1290–1296.
63CW Lee , WN Lin , CC Lin , (2006) Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation. J Cell Physiol 207, 174–186.
64K Balasubramanyam , RA Varier , M Altaf , (2004) Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 279, 51163–51171.
65SY Roth , JM Denu & CD Allis (2001) Histone acetyltransferases. Annu Rev Biochem 70, 81–120.
66IR Sanderson & S Naik (2000) Dietary regulation of intestinal gene expression. Annu Rev Nutr 20, 311–338.
67G Monteleone , G Del Vecchio Blanco , I Monteleone , (2005) Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129, 1420–1429.
68EM Ongeri , MF Verderame & JM Hammond (2005) Follicle-stimulating hormone induction of ovarian insulin-like growth factor-binding protein-3 transcription requires a TATA box-binding protein and the protein kinase A and phosphatidylinositol-3 kinase pathways. Mol Endocrinol 19, 1837–1848.
69NR White , P Mulligan , PJ King , (2006) Sodium butyrate-mediated Sp3 acetylation represses human insulin-like growth factor binding protein-3 expression in intestinal epithelial cells. J Pediatr Gastroenterol Nutr 42, 134–141.
70XJ Yang (2004) The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 32, 959–976.
71CL Brooks & W Gu (2003) Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 15, 164–171.
73Y Chen , W Shu , W Chen , (2007) Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 101, 427–433.
74RB Heuschkel , CC Menache , JT Megerian , (2000) Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 31, 8–15.
75K Bannerjee , C Camacho-Hubner , K Babinska , (2004) Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 38, 270–275.
76K Goh & SD Xiao (2009) Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis 10, 1–6.
77SM Montgomery , DL Morris , RE Pounder , (1999) Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 11, 543–546.
78YT Jian , GF Mai , JD Wang , (2005) Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 11, 1747–1752.
79K Sugimoto , H Hanai , K Tozawa , (2002) Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123, 1912–1922.
80K Nones , B Knoch , YE Dommels , (2009) Multidrug resistance gene deficient (mdr1a( − / − )) mice have an altered caecal microbiota that precedes the onset of intestinal inflammation. J Appl Microbiol 107, 557–566.
81MV Venkataranganna , M Rafiq , S Gopumadhavan , (2007) NCB-02 (standardized Curcumin preparation) protects dinitrochlorobenzene- induced colitis through down-regulation of NFkappa-B and iNOS. World J Gastroenterol 13, 1103–1107.
82C Billerey-Larmonier , JK Uno , N Larmonier , (2008) Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent. Inflamm Bowel Dis 14, 780–793.
84CV Rao , B Simi & BS Reddy (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219–2225.
85JM Kim , S Araki , DJ Kim , (1998) Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19, 81–85.
86J Ushida , S Sugie , K Kawabata , (2000) Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res 91, 893–898.
88SE Chuang , AL Cheng , JK Lin , (2000) Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38, 991–995.
89MA Azuine & SV Bhide (1992) Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis. Int J Cancer 51, 412–415.
91SS Hecht , PM Kenney , M Wang , (1999) Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 137, 123–130.
92Y Okazaki , M Iqbal & S Okada (2005) Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 1740, 357–366.
93P Sindhwani , JA Hampton , MM Baig , (2001) Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J Urol 166, 1498–1501.
94P Limtrakul , S Lipigorngoson , O Namwong , (1997) Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116, 197–203.
95R Kuttan , P Bhanumathy , K Nirmala , (1985) Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29, 197–202.
96J Odot , P Albert , A Carlier , (2004) In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells. Int J Cancer 111, 381–387.
97MM LoTempio , MS Veena , HL Steele , (2005) Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11, (19 Pt 1), 6994–7002.
98T Dorai , YC Cao , B Dorai , (2001) Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo. Prostate 47, 293–303.
99AB Kunnumakkara , S Guha , S Krishnan , (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67, 3853–3861.
100L Li , FS Braiteh & R Kurzrock (2005) Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer 104, 1322–1331.
101L Li , B Ahmed , K Mehta , (2007) Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 6, 1276–1282.
102Y Ohashi , Y Tsuchiya , K Koizumi , (2003) Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model. Oncology 65, 250–258.
103BB Aggarwal , S Shishodia , Y Takada , (2005) Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490–7498.
104B Bachmeier , AG Nerlich , CM Iancu , (2007) The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19, 137–152.
105YG Lin , AB Kunnumakkara , A Nair , (2007) Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res 13, 3423–3430.
106G Kobelt (2006) Health economic issues in rheumatoid arthritis. Scand J Rheumatol 35, 415–425.
108MC Heng , MK Song , J Harker , (2000) Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143, 937–949.
110B Lal , AK Kapoor , PK Agrawal , (2000) Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 14, 443–447.
111B Lal , AK Kapoor , OP Asthana , (1999) Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13, 318–322.
112R Bundy , AF Walker , RW Middleton , (2004) Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: a pilot study. J Altern Complement Med 10, 1015–1018.
114C Niederau & E Gopfert (1999) The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study. Med Klin (Munich) 94, 425–430.
115A Rasyid & A Lelo (1999) The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther 13, 245–249.
116A Rasyid , AR Rahman , K Jaalam , (2002) Effect of different curcumin dosages on human gall bladder. Asia Pac J Clin Nutr 11, 314–318.
118M Cruz-Correa , DA Shoskes , P Sanchez , (2006) Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4, 1035–1038.
120P Usharani , AA Mateen , MU Naidu , (2008) Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D 9, 243–250.
121D Shoskes , C Lapierre , M Cruz-Correa , (2005) Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial. Transplantation 80, 1556–1559.
122PR Holt , S Katz & R Kirshoff (2005) Curcumin therapy in inflammatory bowel disease: a pilot study. Dig Dis Sci 50, 2191–2193.
123H Hanai , T Iida , K Takeuchi , (2006) Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4, 1502–1506.
126N Dhillon , BB Aggarwal , RA Newman , (2008) Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res 14, 4491–4499.
127L Baum , CW Lam , SK Cheung , (2008) Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28, 110–113.
128G Liang , H Zhou , Y Wang , (2009) Inhibition of LPS-induced production of inflammatory factors in the macrophages by mono-carbonyl analogues of Curcumin. J Cell Mol Med.
129WM Weber , LA Hunsaker , AM Gonzales , (2006) TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochem Pharmacol 72, 928–940.
130R Olszanecki , A Gebska & R Korbut (2007) The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol 101, 411–415.
131M Srinivasan , N Rajendra Prasad & VP Menon (2006) Protective effect of curcumin on gamma-radiation induced DNA damage and lipid peroxidation in cultured human lymphocytes. Mutat Res 611, 96–103.
132E Balogun , M Hoque , P Gong , (2003) Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371 (Pt 3), 887–895.
133YF Liao , HC Hung , TC Hour , (2008) Curcumin induces apoptosis through an ornithine decarboxylase-dependent pathway in human promyelocytic leukemia HL-60 cells. Life Sci 82, 367–375.
134JB Wang , LL Qi , SD Zheng , (2009) Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci 10, 93–102.
135AR Hussain , M Al-Rasheed , PS Manogaran , (2006) Curcumin induces apoptosis via inhibition of PI3′-kinase/AKT pathway in acute T cell leukemias. Apoptosis 11, 245–254.
136JY Liu , SJ Lin & JK Lin (1993) Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14, 857–861.
137UR Pendurthi & LV Rao (2000) Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97, 179–189.
139GP Collett , CN Robson , JC Mathers , (2001) Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis 22, 821–825.
140CV Rao , A Rivenson , B Simi , (1995) Chemoprevention of colon cancer by dietary curcumin. Ann N Y Acad Sci 768, 201–204.
142MA Pereira , CJ Grubbs , LH Barnes , (1996) Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17, 1305–1311.
143Y Kwon , M Malik & BA Magnuson (2004) Inhibition of colonic aberrant crypt foci by curcumin in rats is affected by age. Nutr Cancer 48, 37–43.
144B Shpitz , N Giladi , E Sagiv , (2006) Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model. Digestion 74, 140–144.
145SR Volate , DM Davenport , SJ Muga , (2005) Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26, 1450–1456.
146Y Kwon & BA Magnuson (2007) Effect of azoxymethane and curcumin on transcriptional levels of cyclooxygenase-1 and -2 during initiation of colon carcinogenesis. Scand J Gastroenterol 42, 72–80.
149SJ Kim & MK Hellerstein (2007) Pharmacological doses of dietary curcumin increase colon epithelial cell proliferation in vivo in rats. Phytother Res 21, 995–998.
150MA Azuine & SV Bhide (1992) Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17, 77–83.
151SV Singh , X Hu , SK Srivastava , (1998) Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19, 1357–1360.
153MV Swamy , B Citineni , JM Patlolla , (2008) Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer 60, Suppl. 1, 81–89.
155CC Lin , YP Lu , YR Lou , (2001) Inhibition by dietary dibenzoylmethane of mammary gland proliferation, formation of DMBA-DNA adducts in mammary glands, and mammary tumorigenesis in Sencar mice. Cancer Lett 168, 125–132.
156K Singletary , C MacDonald , M Wallig , (1996) Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103, 137–141.
157SS Deshpande , AD Ingle & GB Maru (1998) Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis. Cancer Lett 123, 35–40.
158H Inano & M Onoda (2002) Radioprotective action of curcumin extracted from Curcuma longa LINN: inhibitory effect on formation of urinary 8-hydroxy-2′-deoxyguanosine, tumorigenesis, but not mortality, induced by gamma-ray irradiation. Int J Radiat Oncol Biol Phys 53, 735–743.
159H Inano , M Onoda , N Inafuku , (1999) Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis 20, 1011–1018.
161C Ishizaki , T Oguro , T Yoshida , (1996) Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-O-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 193, 311–317.
163YP Lu , RL Chang , MT Huang , (1993) Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293–297.
164MT Huang , W Ma , YP Lu , (1995) Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16, 2493–2497.
165MT Huang , W Ma , P Yen , (1997) Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18, 83–88.
166KK Soudamini & R Kuttan (1989) Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 27, 227–233.
167MT Huang , EE Deschner , HL Newmark , (1992) Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 64, 117–121.
168BM William , A Goodrich , C Peng , (2008) Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia. Hematology 13, 333–343.
169B Sung , AB Kunnumakkara , G Sethi , (2009) Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model. Mol Cancer Ther 8, 959–970.
170M Iqbal , Y Okazaki & S Okada (2009) Curcumin attenuates oxidative damage in animals treated with a renal carcinogen, ferric nitrilotriacetate (Fe-NTA): implications for cancer prevention. Mol Cell Biochem 324, 157–164.
171S Purkayastha , A Berliner , SS Fernando , (2009) Curcumin blocks brain tumor formation. Brain Res.
172NK Narayanan , D Nargi , C Randolph , (2009) Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice. Int J Cancer 125, 1–8.